GS
Insider selling
Gaurav Shah sold $7K of Rocket Pharmaceuticals, Inc. (RCKT) stock
Gaurav Shah, CEO of Rocket Pharmaceuticals, Inc. (RCKT), sold 2,409 shares of RCKT stock worth $7K, per an SEC Form 4 filed May 21, 2026.
It was an open-market sale.
The trade happened on May 19, 2026, 2 days before it was made public.
RCKT has moved +12.0% since the trade date, from $2.92 to $3.27 (Sep 21, 2026 close).
- Traded
- May 19, 2026
- Disclosed
- May 21, 2026
- Filing delay
- 2 days
- Price since
- +12.0%
- Role
- CEO
- Source
- SEC Form 4
More RCKT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.